Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.

BMC Med · 2018 · PMC5979000 · PMID 29690878

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to being statistically significantno p-value reported

In a more recent trial, MB monotherapy in 60 West African adults with falciparum malaria (a fixed dose of 780 mg for 3 days) showed a 100% cure rate when MB was given for 7 days compared to a 85% cure rate when MB was given for a shorter time period; this difference was close to being statistically significant [ 59 ].

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.